clinical trial · NCT04144192
Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
Scilex Pharmaceuticals, Inc.·phase1·completed·n = 58
HealthyLidocaine patch 1.8%Lidocaine 5% patchLidocaine 2% Injectable Solution
brief summary
The purpose of this study is to characterize the comparative single-dose pharmacokinetics (bioequivalence) of lidocaine patch 1.8% (investigational product) versus Lidoderm® (lidocaine patch 5%,reference product).
started
Apr 28, 2014
primary completion
Jul 24, 2014
completion
Jul 24, 2014
last updated
May 23, 2024
official title
Phase 1, Randomized, Comparative Pharmacokinetic Study of Bolus Intravenous Lidocaine 0.7 mg/kg, Lidocaine Patch 1.8%, and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol